(Q46835283)

25 December 2017

title

Role of asymmetric dimethylarginine for angiotensin II-induced target organ damage in mice (English)

1 reference

25 December 2017

5

Roland E Schmieder

1 reference

25 December 2017

author name string

Johannes Jacobi

1

1 reference

25 December 2017

Renke Maas

2

1 reference

25 December 2017

Nada Cordasic

3

1 reference

25 December 2017

Kilian Koch

4

1 reference

25 December 2017

Rainer H Böger

6

1 reference

25 December 2017

Karl F Hilgers

7

1 reference

25 December 2017

publication date

21 December 2007

1 reference

25 December 2017

American Journal of Physiology Heart and Circulatory Physiology

published in

1 reference

25 December 2017

volume

294

1 reference

25 December 2017

issue

2

1 reference

25 December 2017

page(s)

H1058-66

1 reference

25 December 2017

Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01103.2007

Endothelial dihydrofolate reductase: critical for nitric oxide bioavailability and role in angiotensin II uncoupling of endothelial nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01103.2007

Long-term angiotensin-converting enzyme inhibition reduces plasma asymmetric dimethylarginine and improves endothelial nitric oxide bioavailability and coronary microvascular function in patients with syndrome X.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01103.2007

Role of asymmetric dimethylarginine in inflammatory reactions by angiotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01103.2007

Dimethylarginine dimethylaminohydrolase regulates nitric oxide synthesis: genetic and physiological evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01103.2007

Angiotensin converting enzyme inhibition and angiotensin II AT1-receptor blockade reduce the levels of asymmetrical N(G), N(G)-dimethylarginine in human essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01103.2007

Chronic angiotensin II receptor blockade reduces (intra)renal vascular resistance in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01103.2007

Strain differences in the development of hypertension and glomerular lesions induced by deoxycorticosterone acetate salt in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01103.2007

Angiotensin-converting enzyme activity is involved in the mechanism of increased endogenous nitric oxide synthase inhibitor in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01103.2007

Renin-angiotensin system is involved in the mechanism of increased serum asymmetric dimethylarginine in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01103.2007

S-nitrosylation of dimethylarginine dimethylaminohydrolase regulates enzyme activity: further interactions between nitric oxide synthase and dimethylarginine dimethylaminohydrolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01103.2007

Disruption of methylarginine metabolism impairs vascular homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01103.2007

A concordance correlation coefficient to evaluate reproducibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01103.2007

Determination of asymmetric dimethylarginine: liquid chromatography-mass spectrometry or ELISA?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01103.2007

Reference values for plasma concentrations of asymmetrical dimethylarginine (ADMA) and other arginine metabolites in men after validation of a chromatographic method

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01103.2007

Asymmetrical dimethylarginine independently predicts total and cardiovascular mortality in individuals with angiographic coronary artery disease (the Ludwigshafen Risk and Cardiovascular Health study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01103.2007

Immunosuppressive treatment protects against angiotensin II-induced renal damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01103.2007

Expression of NG,NG-dimethylarginine dimethylaminohydrolase and protein arginine N-methyltransferase isoforms in diabetic rat kidney: effects of angiotensin II receptor blockers

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01103.2007

Asymmetric dimethylarginine, L-arginine, and endothelial dysfunction in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01103.2007

Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01103.2007

Asymmetric dimethylarginine and the risk of cardiovascular events and death in patients with coronary artery disease: results from the AtheroGene Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01103.2007

Determination of asymmetric dimethylarginine (ADMA) using a novel ELISA assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01103.2007

Asymmetric dimethylarginine produces vascular lesions in endothelial nitric oxide synthase-deficient mice: involvement of renin-angiotensin system and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01103.2007

Reduced urinary excretion of nitric oxide metabolites and increased plasma levels of asymmetric dimethylarginine in men with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01103.2007

ADMA and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01103.2007

Cardiovascular biology of the asymmetric dimethylarginine:dimethylarginine dimethylaminohydrolase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01103.2007

Sex differences in the development of angiotensin II-induced hypertension in conscious mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01103.2007

10.1152/AJPHEART.01103.2007

21 January 2018

Identifiers

DOI

1 reference

25 December 2017

1 reference

25 December 2017